Growth Metrics

Quest Diagnostics (DGX) Shares Issued (2016 - 2026)

Quest Diagnostics' Shares Issued history spans 18 years, with the latest figure at $65.0 million for Q1 2026.

  • On a quarterly basis, Shares Issued rose 124.14% to $65.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $115.0 million, a 27.78% increase, with the full-year FY2025 number at $79.0 million, up 8.22% from a year prior.
  • Shares Issued hit $65.0 million in Q1 2026 for Quest Diagnostics, up from $18.0 million in the prior quarter.
  • Over the last five years, Shares Issued for DGX hit a ceiling of $65.0 million in Q1 2026 and a floor of $10.0 million in Q1 2022.
  • Historically, Shares Issued has averaged $24.2 million across 5 years, with a median of $21.0 million in 2024.
  • The widest YoY moves for Shares Issued: up 150.0% in 2023, down 62.07% in 2023.
  • Tracing DGX's Shares Issued over 5 years: stood at $27.0 million in 2022, then plummeted by 55.56% to $12.0 million in 2023, then soared by 75.0% to $21.0 million in 2024, then dropped by 14.29% to $18.0 million in 2025, then skyrocketed by 261.11% to $65.0 million in 2026.
  • Business Quant data shows Shares Issued for DGX at $65.0 million in Q1 2026, $18.0 million in Q4 2025, and $19.0 million in Q3 2025.